Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 163

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 163
---
041 $42,296 Work in process51,785 59,727 Finished products (1)183,718 278,236 Inventories$278,544 $380,259 (1) This balance is net of an approximate $27 million write down as of December 28, 2024, associated with the carrying value of assets currently associated with the February 16, 2023, Cambodia-sourced non-human primate matter. See Note 18. Commitments and Contingencies

Inventory step up amortization expense incurred in fiscal year 2024 was $27.7 million. 

79

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

7. PROPERTY, PLANT AND EQUIPMENT, NET

The composition of property, plant and equipment, net is as follows: December 28, 2024December 30, 2023(in thousands)Land$71,736 $79,546 Buildings (1)1,069,667 1,053,915 Machinery and equipment (1)1,029,424 984,867 Leasehold improvements438,746 366,556 Furniture and fixtures30,413 31,284 Computer hardware and software (1)268,032 254,413 Vehicles (1)6,800 6,746 Construction in progress143,306 197,723 Total3,058,124 2,975,050 Less: Accumulated depreciation(1,454,110)(1,335,309)Property, plant and equipment, net$1,604,014 $1,639,741 (1) These balances include assets under finance leases. See Note 17. Leases.Depreciation expense in fiscal years 2024, 2023 and 2022 was $190.2 million, $176.7 million, and $157.3 million, respectively.

8. VENTURE CAPITAL AND STRATEGIC EQUITY INVESTMENTS

Venture capital investments are summarized below:December 28, 2024December 30, 2023December 31, 2022(in thousands)Beginning balance$121,158 $129,012 $149,640 Capital contributions22,063 17,410 14,485 Distributions(23,023)(15,685)(